Lung cancer mortality trends in China from 2013 to 2021 and projections to 2030.
1/5 보강
[OBJECTIVE] This study was aimed at analyzing temporal trends in lung cancer mortality from 2013 to 2021, and projecting future trends until 2030.
APA
Liang X, Li X, et al. (2026). Lung cancer mortality trends in China from 2013 to 2021 and projections to 2030.. Cancer biology & medicine. https://doi.org/10.20892/j.issn.2095-3941.2025.0625
MLA
Liang X, et al.. "Lung cancer mortality trends in China from 2013 to 2021 and projections to 2030.." Cancer biology & medicine, 2026.
PMID
41870348 ↗
Abstract 한글 요약
[OBJECTIVE] This study was aimed at analyzing temporal trends in lung cancer mortality from 2013 to 2021, and projecting future trends until 2030.
[METHODS] Mortality data were extracted from the China Causes of Death Surveillance Dataset, which covers 2.37 billion person-years. Age-standardized mortality rates (ASMRs) were calculated with Segi's world standard population. Joinpoint regression was used to analyze temporal trends, and linear regression was applied to assess changes in mean age at death. A Bayesian age-period-cohort model was used to project mortality trends through 2030. Contributions of risk factors and demographic changes (population size and age structure) to mortality trends were decomposed with the population split method.
[RESULTS] From 2013 to 2021, the crude lung cancer mortality rate increased by 2.3% annually, whereas the ASMR remained stable overall but showed significant 2.9% annual declines during 2015 and 2021. The ASMRs in urban areas (-2.9% per year) and eastern regions (-1.5% per year) showed significant decreasing trends throughout the entire period. The mean age at death increased across all areas, and the largest increases were observed in rural areas. Deaths among people ≥65 years of age rose by 1.6%-5.6% during the entire period. Decomposition analysis indicated that the increased death counts were driven primarily by population aging (32%-43%) and population growth (8%-31%), whereas risk factors contributed negatively (-3% to -29%). Projections suggested that the number of lung cancer deaths will reach approximately 760,200 by 2030, with continued increases in the crude mortality rate but slight declines in the ASMR.
[CONCLUSIONS] The lung cancer burden in China shows marked regional disparities and challenges due to population aging. To further decrease lung cancer deaths, optimized allocation of medical resources, strengthened prevention and control of lung cancer risk factors, and integration of effective policies will be required.
[METHODS] Mortality data were extracted from the China Causes of Death Surveillance Dataset, which covers 2.37 billion person-years. Age-standardized mortality rates (ASMRs) were calculated with Segi's world standard population. Joinpoint regression was used to analyze temporal trends, and linear regression was applied to assess changes in mean age at death. A Bayesian age-period-cohort model was used to project mortality trends through 2030. Contributions of risk factors and demographic changes (population size and age structure) to mortality trends were decomposed with the population split method.
[RESULTS] From 2013 to 2021, the crude lung cancer mortality rate increased by 2.3% annually, whereas the ASMR remained stable overall but showed significant 2.9% annual declines during 2015 and 2021. The ASMRs in urban areas (-2.9% per year) and eastern regions (-1.5% per year) showed significant decreasing trends throughout the entire period. The mean age at death increased across all areas, and the largest increases were observed in rural areas. Deaths among people ≥65 years of age rose by 1.6%-5.6% during the entire period. Decomposition analysis indicated that the increased death counts were driven primarily by population aging (32%-43%) and population growth (8%-31%), whereas risk factors contributed negatively (-3% to -29%). Projections suggested that the number of lung cancer deaths will reach approximately 760,200 by 2030, with continued increases in the crude mortality rate but slight declines in the ASMR.
[CONCLUSIONS] The lung cancer burden in China shows marked regional disparities and challenges due to population aging. To further decrease lung cancer deaths, optimized allocation of medical resources, strengthened prevention and control of lung cancer risk factors, and integration of effective policies will be required.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- The Ideal Nasion in Chinese: A Preference Analysis of the General Population.
- A Look Behind the Paper: Glypican-3-targeted US Molecular Imaging of Hepatocellular Carcinoma.
- US Molecular Imaging of Glypican-3 Expression in Hepatocellular Carcinoma Using Targeted Biosynthetic Gas Vesicles.
- Cost-effectiveness analysis of capivasertib plus fulvestrant in the -altered subgroup with HR+/HER2- advanced breast cancer: a United States payer perspective.
- From Thresholds to Tumor Sidedness: Reframing Human Epidermal Growth Factor Receptor 2 in Colorectal Cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- A herbal formulation inhibits growth and survival of lung cancer cells through DNA damage and apoptosis - in vitro and in vivo studies.
- Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.
- Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).
- Retrospective dosimetric evaluation of the collapsed cone, AAA, and Acuros XB algorithms for lung cancer Halcyon VMAT plans.